AnaptysBio, Inc.
AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-3…
Biotechnology
US, San Diego [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
AnaptysBio, Inc. has no acquisition track records yet.
M&A Deals · History
AnaptysBio, Inc. has no acquisition track records yet.